Guggenheim Capital’s PHYSICIANS REALTY TRUST DOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-155,992
| Closed | -$2.08M | – | 1975 |
|
|
2023
Q4 | $2.08M | Sell |
155,992
-368,220
| -70% | -$4.37M | 0.02% | 833 |
|
|
2023
Q3 | $6.39M | Sell |
524,212
-37,508
| -7% | -$518K | 0.05% | 415 |
|
|
2023
Q2 | $7.86M | Sell |
561,720
-176,194
| -24% | -$2.5M | 0.06% | 372 |
|
|
2023
Q1 | $11M | Sell |
737,914
-10,944
| -1% | -$165K | 0.09% | 256 |
|
|
2022
Q4 | $10.8M | Buy |
748,858
+2,399
| +0.3% | +$34.8K | 0.1% | 265 |
|
|
2022
Q3 | $11.2M | Buy |
746,459
+3,838
| +0.5% | +$64.8K | 0.1% | 237 |
|
|
2022
Q2 | $13M | Sell |
742,621
-17,151
| -2% | -$303K | 0.1% | 236 |
|
|
2022
Q1 | $13.3M | Buy |
759,772
+26,397
| +4% | +$464K | 0.08% | 297 |
|
|
2021
Q4 | $13.8M | Buy |
733,375
+2,845
| +0.4% | +$52.4K | 0.07% | 309 |
|
|
2021
Q3 | $12.9M | Buy |
730,530
+26,540
| +4% | +$491K | 0.08% | 297 |
|
|
2021
Q2 | $13M | Buy |
703,990
+5,327
| +0.8% | +$99.1K | 0.08% | 307 |
|
|
2021
Q1 | $12.3M | Buy |
698,663
+13,140
| +2% | +$233K | 0.08% | 297 |
|
|
2020
Q4 | $12.2M | Buy |
685,523
+1,014
| +0.1% | +$18.2K | 0.08% | 273 |
|
|
2020
Q3 | $12.3M | Sell |
684,509
-11,607
| -2% | -$207K | 0.09% | 225 |
|
|
2020
Q2 | $12.2M | Sell |
696,116
-11,295
| -2% | -$184K | 0.09% | 213 |
|
|
2020
Q1 | $9.86M | Sell |
707,411
-27,879
| -4% | -$512K | 0.1% | 211 |
|
|
2019
Q4 | $13.9M | Buy |
735,290
+759
| +0.1% | +$13.9K | 0.1% | 223 |
|
|
2019
Q3 | $13M | Sell |
734,531
-14,725
| -2% | -$256K | 0.1% | 224 |
|
|
2019
Q2 | $13.1M | Buy |
749,256
+1,420
| +0.2% | +$25.8K | 0.11% | 213 |
|
|
2019
Q1 | $14.1M | Sell |
747,836
-7,079
| -0.9% | -$126K | 0.11% | 194 |
|
|
2018
Q4 | $12.1M | Buy |
754,915
+25,026
| +3% | +$419K | 0.1% | 201 |
|
|
2018
Q3 | $12.3M | Buy |
729,889
+383,358
| +111% | +$6.36M | 0.08% | 279 |
|
|
2018
Q2 | $5.53M | Sell |
346,531
-47,835
| -12% | -$723K | 0.04% | 653 |
|
|
2018
Q1 | $6.14M | Sell |
394,366
-327,769
| -45% | -$5.14M | 0.02% | 896 |
|
|
2017
Q4 | $13M | Buy |
722,135
+134,748
| +23% | +$2.42M | 0.03% | 612 |
|
|
2017
Q3 | $10.4M | Buy |
587,387
+76,610
| +15% | +$1.41M | 0.02% | 667 |
|
|
2017
Q2 | $10.3M | Buy |
510,777
+18,509
| +4% | +$376K | 0.03% | 661 |
|
|
2017
Q1 | $9.78M | Buy |
492,268
+25,555
| +5% | +$488K | 0.03% | 681 |
|
|
2016
Q4 | $8.85M | Buy |
466,713
+91,516
| +24% | +$1.73M | 0.03% | 712 |
|
|
2016
Q3 | $8.08M | Sell |
375,197
-30,148
| -7% | -$637K | 0.03% | 762 |
|
|
2016
Q2 | $8.52M | Buy |
405,345
+246,102
| +155% | +$4.72M | 0.03% | 743 |
|
|
2016
Q1 | $2.96M | Buy |
159,243
+136,193
| +591% | +$2.35M | 0.01% | 1304 |
|
|
2015
Q4 | $389K | Buy |
23,050
+10,144
| +79% | +$161K | ﹤0.01% | 2552 |
|
|
2015
Q3 | $195K | Buy |
+12,906
| New | +$198K | ﹤0.01% | 2740 |
|
|
2015
Q2 | – | Sell |
-19,241
| Closed | -$339K | – | 3190 |
|
|
2015
Q1 | $339K | Buy |
19,241
+2,494
| +15% | +$42.1K | ﹤0.01% | 2665 |
|
|
2014
Q4 | $278K | Buy |
+16,747
| New | +$256K | ﹤0.01% | 2707 |
|
Other funds holding DOC
CWM
IWA
AMG
AIP
VIM
CASC
BRWA
IA
HNB
Guggenheim Capital's DOC Position: Q1 2024 in Review
Guggenheim Capital sold out of PHYSICIANS REALTY TRUST (DOC) in Q1 2024, closing a stake of 155,992 shares — an estimated $2.08M sold.
Guggenheim Capital first reported a position in DOC in Q4 2014 and held it in 36 quarters. The position peaked at $14.1M in Q1 2019. 9 funds tracked by Wall St. Rank hold DOC as of Q1 2024.
- Guggenheim Capital reported no remaining PHYSICIANS REALTY TRUST position as of Q1 2024 after selling out during the quarter.
- Guggenheim Capital sold 155,992 PHYSICIANS REALTY TRUST shares in Q1 2024, an estimated $2.08M.
- Guggenheim Capital first reported a position in PHYSICIANS REALTY TRUST in Q4 2014 and held it in 36 quarters.
- Guggenheim Capital's PHYSICIANS REALTY TRUST position peaked at $14.1M in Q1 2019.
- 9 funds tracked by Wall St. Rank held PHYSICIANS REALTY TRUST as of Q1 2024.
Based on Guggenheim Capital's 13F filing for Q1 2024, filed 14 May 2024.